Advanced search
Publication Cover
Pathology Volume 42, 2010 - Issue 4: Special Theme Issue: Genitourinary Pathology. Invited Guest Editors: Hemamali Samaratunga and Jonathan I. Epstein
Submit an article Journal homepage
32
Views
2
CrossRef citations to date
0
Altmetric
Bladder

Papillary urothelial hyperplasia: relationship to urothelial neoplasms

Nathaniel Readal *Johns Hopkins Medical School
&
Jonathan I. Epstein †The Departments of Pathology, Urology, and Oncology, Johns Hopkins Hospital Medical Institutions, Baltimore, MD, USACorrespondence[email protected]
Pages 360-363 | Published online: 04 May 2010

References

  • Koss LG. Atlas of Tumor Pathology: Tumors of the Urinary Bladder. Second Series, Fascicle 2, Washington DC: Armed Forces Institute of Pathology, 1975.
  • Sarma KP. Genesis of papillary tumours: histological and microangiographic study. Br J Urol 1981; 53: 228–236.
  • Taylor DC, Bhagavan BS, Larsen MP, Cox JA, Epstein JI. Papillary urothelial hyperplasia. A precursor to papillary neoplasms. Am J Surg Pathol 1996; 20: 1481–1488.
  • Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435–1448.
  • Swierczynski SL, Epstein JI. Prognostic significance of atypical papillary urothelial hyperplasia. Hum Pathol 2002; 33: 512–517.
  • Eagan JWJ. Urothelial neoplasms. In: Hill GS, editor. Uropathology. New York: Churchill Livingstone, 1990; 728–729.
  • Bracken RB, Mackay B. Atlas of Bladder Pathology. New York: Igaku-Shoin, 1991; 105–106.
  • Epstein JI. Differential Diagnoses in Pathology: Urologic Disorders. New York: Igaku-Shoin, 1992; 38–39.
  • Young RH. Pathology of the Urinary Bladder. New York: Churchill Livingstone, 1989.
  • Chow NH, Cairns P, Eisenberger CF, et al Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 2000; 89: 514–518.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.